Managing Director
Bain Capital Life Sciences
Jeffrey Schwartz is a Managing Director of Bain Capital Life Sciences, where he is a founding member of the team. Prior to co-founding Bain Capital Life Sciences in 2016, he was a leader within the healthcare vertical of Bain Capital Private Equity. He currently is a board member of Gynesonics, Hugel, QuVa Pharma, Rapid Micro Biosystems and SpringWorks Therapeutics. Since joining Bain Capital, Mr. Schwartz has been actively involved in a wide spectrum of healthcare companies in which Bain Capital Private Equity has made investments including: Air Medical Group Holdings, Beacon Health Options, CRC Health, HCA, Lake Region Medical, Quintiles, and Warner Chilcott. In addition, he currently sits on the board of the Commonwealth School, the Boston Medical Center Philanthropic Trust and Boston Medical Center HealthNet Plan. Prior to joining Bain Capital, Mr. Schwartz served as an Equity Research Analyst at Lehman Brothers, working in both New York and London. Mr. Schwartz received an MBA from The Wharton School at the University of Pennsylvania, where he was a Palmer Scholar. He graduated magna cum laude from Yale University with a BA in economics.
None yet.